The Department of Pediatrics at the UW School of Medicine and Public Health was ranked 9th in the nation among medical school pediatric departments receiving research funding from the National Institutes of Health (NIH), according to Blue Ridge Institute for Medical Research. The recently released rankings report the department received more than $36 million in research grants during the NIH’s 2022 fiscal year, which ran from October 1, 2021, to September 30, 2022. In total, 21 department faculty members served as PIs on NIH research grants during that timeframe.
“The NIH funding climate is highly competitive, and this ranking reflects our continued commitment to research excellence,” said Megan Moreno, MD, MSEd, MPH, professor, Division of General Pediatrics and Adolescent Medicine, and interim chair. “This achievement is shared throughout the department, from our innovative researchers and dedicated research administration staff to everyone who contributes to our mission to promote and enhance the health of children everywhere.”
James Gern, MD, professor and chief, Division of Allergy, Immunology, and Rheumatology, and vice chair of research, describes the department’s research program as diverse and robust. “Investigation in our department spans basic science, translational, and clinical trials research across nearly all of our divisions,” Gern said. “Our PIs are members of national consortiums, collaborate in cross-campus research, and provide mentorship and support to the next generation of pediatrics investigators — all factors that contribute to research success in our department.”
This is the second year in a row the department ranked in the Top 10, and the department’s fourth Top 10 ranking in six years. The department has been steadily climbing the rankings for nearly two decades, up from No. 44 in 2006. Other UW School of Medicine and Public Health departments with rankings in the Top 10 for their specialties in 2022 include Urology (7th) and Surgery (7th).
Read more about the Department of Pediatrics’ research success in its 2022 Annual Report.